Menu

Markets

Research

News

Learn

AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Elicio Therapeutics, Inc. ELTX

Full chart Compare
Set alert

Price alert · ELTX

All alert types
1.40 USD -0.16 (-10.26%)

At closeNov 6, 2026, 8:17 AM EST

1.40 0.00 0.00%

Pre-market · Nov 6, 8:17 AM ET

1.40 Day range 1.66
1.40 52-week range 16.00
YTD
-82.41%
1 year
-84.56%

Financial health

Altman Z-Score

-11.10 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Rating

C2 / 5 overall

  • DCF 2
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 2
  • P/E 1
  • P/B 3

Valuation

P/E -3.1×
FY 2012: 0.1×FY 2013: 0.1×FY 2018: -0.9×FY 2019: -3.9×FY 2020: -3.1×FY 2021: -0.3×FY 2022: -0.6×FY 2023: -1.2×FY 2024: -1.2×FY 2025: -3.1×
FY 2012 5y median -1.2× FY 2025
P/S 0.0×
FY 2012: 0.0×FY 2013: 0.0×FY 2018: 4.3×FY 2019: 32.3×FY 2020: 16.7×FY 2021: 0.7×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2012 5y median 0.0× FY 2025
P/B 74.5×
FY 2012: 0.0×FY 2013: 0.0×FY 2018: 0.9×FY 2019: -2.6×FY 2020: -0.5×FY 2021: 0.2×FY 2022: 2.0×FY 2023: 3.7×FY 2024: -5.5×FY 2025: 74.5×
FY 2012 5y median 2.0× FY 2025
P/FCF -3.3×
FY 2012: 0.0×FY 2013: 0.0×FY 2018: -2.2×FY 2019: -1.9×FY 2020: -2.1×FY 2021: -0.8×FY 2022: -0.8×FY 2023: -1.3×FY 2024: -1.7×FY 2025: -3.3×
FY 2012 5y median -1.3× FY 2025
EV/EBITDA -3.2×
FY 2012: 2.1×FY 2013: 52.8×FY 2018: 0.6×FY 2019: -1.3×FY 2020: -1.4×FY 2021: 1.2×FY 2022: -0.8×FY 2023: -1.1×FY 2024: -1.4×FY 2025: -3.2×
FY 2012 5y median -1.1× FY 2025
EV/Sales 0.0×
FY 2012: 0.6×FY 2013: 0.5×FY 2018: -2.0×FY 2019: 35.8×FY 2020: 34.2×FY 2021: -2.3×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2012 5y median 0.0× FY 2025
FCF Yield -30.3%
FY 2012: 2822.6%FY 2013: 5200.9%FY 2018: -46.2%FY 2019: -51.7%FY 2020: -47.8%FY 2021: -129.8%FY 2022: -125.1%FY 2023: -77.7%FY 2024: -59.7%FY 2025: -30.3%
FY 2012 5y median -77.7% FY 2025

Profitability

Gross Margin 0.0%
FY 2012: 49.7%FY 2013: 51.8%FY 2018: 90.6%FY 2019: 23.6%FY 2020: 36.9%FY 2021: 95.6%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2012 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2012: -5.7%FY 2013: -6.0%FY 2018: -356.0%FY 2019: -2595.2%FY 2020: -1919.2%FY 2021: -138.8%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2012 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2012: 4.2%FY 2013: 9.6%FY 2018: -497.0%FY 2019: -2734.2%FY 2020: -2781.5%FY 2021: -93.2%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2012 5y median 0.0% FY 2025
ROE -2418.8%
FY 2012: 18.0%FY 2013: 27.0%FY 2018: -105.9%FY 2019: 218.8%FY 2020: 88.6%FY 2021: -32.4%FY 2022: -316.4%FY 2023: -309.5%FY 2024: 458.8%FY 2025: -2418.8%
FY 2012 5y median -309.5% FY 2025
ROIC -201.0%
FY 2012: -3.5%FY 2013: -2.9%FY 2018: -74.4%FY 2019: 494.2%FY 2020: -270.2%FY 2021: -45.6%FY 2022: -143.9%FY 2023: -195.3%FY 2024: -256.2%FY 2025: -201.0%
FY 2012 5y median -195.3% FY 2025
ROA -153.0%
FY 2012: 2.8%FY 2013: 5.7%FY 2018: -75.2%FY 2019: -342.1%FY 2020: -169.2%FY 2021: -27.4%FY 2022: -124.5%FY 2023: -129.7%FY 2024: -184.2%FY 2025: -153.0%
FY 2012 5y median -129.7% FY 2025

Growth (YoY)

Revenue 0.0%
FY 2012: 0.0%FY 2013: -9.8%FY 2018: 0.0%FY 2019: -63.1%FY 2020: 93.7%FY 2021: 883.1%FY 2022: -100.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2012 FY 2025
Operating Income 16.2%
FY 2012: 0.0%FY 2013: 5.1%FY 2018: 0.0%FY 2019: -169.1%FY 2020: -43.2%FY 2021: 28.9%FY 2022: 39.6%FY 2023: -50.6%FY 2024: -25.9%FY 2025: 16.2%
FY 2012 FY 2025
EPS (diluted) 39.3%
FY 2012: 0.0%FY 2013: 105.8%FY 2018: 0.0%FY 2019: 77.9%FY 2020: -28.7%FY 2021: -901.0%FY 2022: 52.9%FY 2023: 23.5%FY 2024: 38.9%FY 2025: 39.3%
FY 2012 FY 2025
Free Cash Flow 0.5%
FY 2012: 0.0%FY 2013: 84.3%FY 2018: 0.0%FY 2019: -209.6%FY 2020: 7.7%FY 2021: -6.7%FY 2022: 6.7%FY 2023: -43.5%FY 2024: -13.4%FY 2025: 0.5%
FY 2012 FY 2025

Financial Health

Current Ratio 2.4×
FY 2012: 1.9×FY 2013: 2.3×FY 2018: 3.5×FY 2019: 0.2×FY 2020: 0.4×FY 2021: 8.1×FY 2022: 1.6×FY 2023: 1.7×FY 2024: 1.8×FY 2025: 2.4×
FY 2012 5y median 1.8× FY 2025
Quick Ratio 2.4×
FY 2012: 1.9×FY 2013: 2.3×FY 2018: 3.5×FY 2019: 0.2×FY 2020: 0.4×FY 2021: 8.1×FY 2022: 1.6×FY 2023: 1.7×FY 2024: 1.8×FY 2025: 2.4×
FY 2012 5y median 1.8× FY 2025
Debt / Equity 8.9×
FY 2012: 3.2×FY 2013: 2.3×FY 2018: 0.0×FY 2019: -0.6×FY 2020: -0.9×FY 2021: 0.1×FY 2022: 0.8×FY 2023: 0.6×FY 2024: -2.3×FY 2025: 8.9×
FY 2012 5y median 0.6× FY 2025
Net Debt / EBITDA 0.1×
FY 2012: 2.1×FY 2013: 52.2×FY 2018: 1.8×FY 2019: -0.1×FY 2020: -0.7×FY 2021: 1.6×FY 2022: 0.0×FY 2023: 0.2×FY 2024: -0.2×FY 2025: 0.1×
FY 2012 5y median 0.1× FY 2025
Interest Coverage -33.3×
FY 2012: -1.4×FY 2013: -1.3×FY 2018: 0.0×FY 2019: 0.0×FY 2020: -6.2×FY 2021: -44.8×FY 2022: -6.6×FY 2023: -33.8×FY 2024: -98.9×FY 2025: -33.3×
FY 2012 5y median -33.8× FY 2025

Dividends

Dividend Yield 0.0%
FY 2012: 0.0%FY 2013: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2012 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2012: 0.0%FY 2013: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2012 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31